Radiographic patterns of relapse in glioblastoma

Journal of Neuro-Oncology

Volumn 101, Issue 2, 2011, Pages 319-323

  Chamberlain, Marc C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bevacizumab; Glioblastoma; MRI; Patterns of relapse; Radiographic

Indexed keywords

BEVACIZUMAB; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN RADIOGRAPHY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651322039     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0251-4     Document Type: Article

References (12)

1. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Eng J Med 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 10.1056/NEJMoa043330 (Pubitemid 40349501)
2. JJ Vredenburgh A Desjardins JE Herndon, et al. 2007 Bevacizumab plus irinotecan in recurrent glioblastoma J Clin Oncol 25 4722 4729 1:CAS:528:DC%2BD2sXhtlCgsLjF 10.1200/JCO.2007.12.2440 17947719 (Pubitemid 350086473)
3. TN Kreisl L Kim K Moore, et al. 2009 Phase II trial of single agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 740 745 1:CAS:528:DC%2BD1MXjsVCjs7o%3D 10.1200/JCO.2008.16.3055 19114704
4. HS Friedman MD Prados PY Wen, et al. 2009 Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 4723 4740 10.1200/JCO.2008.19.8721
5. WB Pope Q Xia A Das, et al. 2009 Patterns of progression in patients with glioblastoma at first or second relapse treated with bevacizumab alone or in combination with irinotecan in the BRAIN study Neuro-Oncology 11 626 (abstract # 270)
6. AD Norden GS Young K Setayesh, et al. 2008 Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 70 779 787 1:CAS:528:DC%2BD1cXitlyqs7o%3D 10.1212/01.wnl.0000304121.57857.38 18316689
7. EC Quant AD Norden J Drappatz, et al. 2009 Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab Neuro-Oncology 11 550 555 1:CAS:528:DC%2BD1MXhtlWht73P 10.1215/15228517-2009-006 19332770
8. J Oh A Sahgal MT Tsao, et al. 2009 Patterns of recurrence of primary glioblastoma multiforme treated with chemoradiation in the temozolomide era Neuro-Oncology 11 623 (abstract #257)
9. FM Iwamoto LE Abrey PH Beal, et al. 2009 Patterns of relapse and prognosis after bevacizumab failure in glioblastoma Neurology 73 1200 1206 1:CAS:528:DC%2BD1MXht1antrfK 10.1212/WNL.0b013e3181bc0184 19822869
10. PH Gutin FM Iwamoto K Beal, et al. 2009 Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas Int J Radiat Oncol Biol 75 1 156 163 1:CAS:528: DC%2BD1MXhtVegsLjO 10.1016/j.ijrobp.2008.10.043
11. DL Silbergeld RC Rostomily EC Alvord 1991 The causes of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults J Neuro-Oncol 10 179 185 1:STN:280:DyaK3MznsVWquw%3D%3D 10.1007/BF00146880
12. P Wen DR Macdonald DA Reardon, et al. 2009 Proposal for an updated response assessment criteria for high-grade gliomas: radiology assessment for neuro-oncology: working group J Clin Oncol 28 1963 1972 10.1200/JCO.2009.26.3541